The cost of concordance with opiate substitution treatment guidelines

Journal of Substance Abuse Treatment

Volumn 39, Issue 2, 2010, Pages 141-149

  Barnett, Paul G ^a,b   Trafton, Jodie A ^a,b   Humphreys, Keith ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Concordance; Cost; MOST study; Opioid substitution program

Indexed keywords

DIAMORPHINE; OPIATE;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA ANALYSIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OPIATE ADDICTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SUBSTITUTION THERAPY;

EID: 77955094006     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.05.012     Document Type: Article

References (30)

1. American Psychiatric Association Position statement on methadone maintenance treatment. The American Journal of Psychiatry 1994, 151:792-794.
2. Ball J.C., Ross A. The effectiveness of methadone maintenance treatment 1991, Springer-Verlag, New York.
3. Barnett P.G., Masson C.L., Sorensen J.L., Wong W., Hall S. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction 2006, 101:1797-1804.
4. Brazier J., Roberts J., Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 2002, 21:271-292.
5. Brugal M.T., Domingo-Salvany A., Puig R., Barrio G., Garcia de Olalla P., de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100:981-989.
6. Clausen T., Anchersen K., Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug and Alcohol Dependence 2008, 94:151-157.
7. D'Aunno T., Pollack H.A. Changes in methadone treatment practices: Results from a national panel study, 1988-2000. Jama 2002, 288:850-856.
8. Esteban J., Gimeno C., Barril J., Aragones A., Climent J.M., de la Cruz Pellin M. Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug and Alcohol Dependence 2003, 70:193-200.
9. Fugelstad A., Stenbacka M., Leifman A., Nylander M., Thiblin I. Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings. Addiction 2007, 102:406-412.
10. Gerstein D.R., Johnson R.A., Harwood H., Fountain D., Suter N., Malloy K. Evaluating recovery services: The California Drug and Alcohol Treatment Assessment (CALDATA) 1994, California Department of Alcohol and Drug Programs, Sacramento, CA.
11. Hoffmann N.G., DeHart S.S., Fulkerson J.A. Medical care utilization as a function of recovery status following chemical addictions treatment. Journal of Addictive Diseases 1993, 12:97-108.
12. Holder H.D., Blose J.O. The reduction of health care costs associated with alcoholism treatment: A 14-year longitudinal study. Journal of Studies on Alcohol 1992, 53:293-302.
13. Humphreys K., Trafton J.A., Oliva E.M. Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment study. Journal of Substance Abuse Treatment 2008, 34:173-179.
14. Kazis L.E., Ren X.S., Lee A., Skinner K., Rogers W., Clark J., et al. Health status in VA patients: Results from the Veterans Health Study. American Journal of Medical Quality 1999, 14:28-38.
15. Kraft M.K., Rothbard A.B., Hadley T.R., McLellan A.T., Asch D.A. Are supplementary services provided during methadone maintenance really cost-effective?. The American Journal of Psychiatry 1997, 154:1214-1219.
16. Mark T.L., Woody G.E., Juday T., Kleber H.D. The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence 2001, 61:195-206.
17. Masson C.L., Sorensen J.L., Batki S.L., Okin R., Delucchi K.L., Perlman D.C. Medical service use and financial charges among opioid users at a public hospital. Drug and Alcohol Dependence 2002, 66:45-50.
18. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., O'Brien C.P. The effects of psychosocial services in substance abuse treatment. JAMA 1993, 269:1953-1959.
19. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992, 9:199-213.
20. Metzger D.S., Navaline H., Woody G.E. Drug abuse treatment as AIDS prevention. Public Health Reports 1998, 113:97-106.
21. NIH Consensus Conference Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998, 280:1936-1943.
22. Rosenheck R., Gallup P., Frisman L.K. Health care utilization and costs after entry into an outreach program for homeless mentally ill veterans. Hospital & Community Psychiatry 1993, 44:1166-1171.
23. Trafton J.A., Humphreys K., Harris A.H., Oliva E. Consistent adherence to guidelines improves opioid dependent patients' first year outcomes. Journal of Behavioral Health Services & Research 2007, 34:260-271.
24. Trafton J.A., Minkel J., Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Med 2006, 3:e80.
25. U.S.Department of Veterans Affairs and Department of Defense VHA/DOD clinical practice guidelines for the management of substance use disorders in the primary care setting. Version 1.0 2004, Washington, D.C.
26. U.S.General Accounting Office Methadone maintenance: Some treatment programs are not effective; Greater federal oversight needed (No. GAO/HRD-90-104) 1990, U.S. General Accounting Office, Washington, DC.
27. Willenbring M.L., Hagedorn H.J., Postier A.C., Kenny M. Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug and Alcohol Dependence 2004, 75:97-106.
28. Zaric G.S., Barnett P.G., Brandeau M.L. HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health 2000, 90:1100-1111.
29. Zarkin G.A., Dunlap L.J., Homsi G. The substance abuse services cost analysis program (SASCAP): A new method for estimating drug treatment services cost. Evaluation and Program Planning 2004, 23:35-43.
30. Zywiak W.H., Hoffmann N.G., Stout R.L., Hagberg S., Floyd A.S., DeHart S.S. Substance abuse treatment cost offsets vary with gender, age, and abstinence likelihood. J Health Care Finance 1999, 26:33-39.